Thermo Fisher 'Going Directly After' $250M Q-TOF Market with Release of New Q Exactive Mass Spec | GenomeWeb

This story originally ran on June 6.

By Adam Bonislawski

DENVER — With the release of its new Q Exactive mass spec instrument at this week's American Society of Mass Spectrometry annual meeting here, Thermo Fisher Scientific is "going directly after the Q-TOF market," Ian Jardine, the company's vice president of global R&D, told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.